Yuta Yamanaka
Hirakata, 5731136, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Should supportive care be started before initiating cancer treatment?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 21, 2026
Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes.
Journal: Japanese journal of clinical oncology
Published: April 29, 2026
Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.
Journal: Translational lung cancer research
Published: February 14, 2026
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 23, 2026
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.
Journal: Molecular therapy. Oncology
Published: January 08, 2026
Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.
Journal: Cancers
Published: December 10, 2025
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.
Journal: Respiratory investigation
Published: August 22, 2025
Exploratory analysis of associations among weight loss, oral function, and dysgeusia in patients with lung cancer undergoing chemotherapy.
Journal: BMC oral health
Published: June 26, 2025
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003).
Journal: JTO clinical and research reports
Published: December 04, 2024
Last Updated: 09/26/2026